Penobscot Investment Management Company, Inc. Gilead Sciences, Inc. Transaction History
Penobscot Investment Management Company, Inc.
- $1.27 Billion
- Q3 2025
A detailed history of Penobscot Investment Management Company, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 3,200 shares of GILD stock, worth $383,328. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,200
Previous 3,200
-0.0%
Holding current value
$383,328
Previous $354,000
0.28%
% of portfolio
0.03%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
2,347Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.09 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.55 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.5 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...